Cargando…

Thyroid disease in insulin-treated patients with type 2 diabetes: a retrospective study

BACKGROUND: Diabetes mellitus and thyroid diseases frequently coexist. In order to evaluate how thyroid disorders interfere with glycemic control, we analysed insulin-treated type 2 diabetes patients with thyroid disease. METHODS: Diabetes patients (n = 1.957) were retrospectively investigated. We f...

Descripción completa

Detalles Bibliográficos
Autores principales: Witting, Valerie, Bergis, Dominik, Sadet, Dilek, Badenhoop, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941259/
https://www.ncbi.nlm.nih.gov/pubmed/24580798
http://dx.doi.org/10.1186/1756-6614-7-2
Descripción
Sumario:BACKGROUND: Diabetes mellitus and thyroid diseases frequently coexist. In order to evaluate how thyroid disorders interfere with glycemic control, we analysed insulin-treated type 2 diabetes patients with thyroid disease. METHODS: Diabetes patients (n = 1.957) were retrospectively investigated. We focused on type 2 diabetes patients who had been admitted for insulin-treatment and diagnosed thyroid diseases (n = 328). Patients were divided into three groups according to thyroid disease manifestation in relation to diabetes onset: prior to (group 1), same year (group 2) and thyroid disease following diabetes (group 3). RESULTS: Out of all diabetes patients 27.3% had a thyroid disorder with more women (62.2%) being affected (p < 0.001). Thyroid disease was predominantly diagnosed after diabetes onset. Patients with type 2 diabetes and prior appearance of thyroid disease required insulin therapy significantly earlier (median insulin-free period: 2.5 yrs; Q(1) = 0.0, Q(3) = 8.25) compared to patients who had thyroid dysfunction after diabetes onset (median insulin-free period: 8.0 yrs; Q(1) = 3.0, Q(3) = 12.0; p < 0.001). Age at diabetes onset correlated with insulin-free period (p < 0.001). CONCLUSIONS: Thyroid disease may be a marker of a distinct metabolic trait in type 2 diabetes potentially requiring earlier insulin treatment.